Chao Peng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Peng, Xinbo Xu, Yaobin Ouyang, Yu Li, Nong Hua Lu, Yin Zhu, Cong He
Spatial Variation of the Gastrointestinal Microbiota in Response to Long-Term Administration of Vonoprazan in Mice With High Risk of Gastric Cancer. Helicobacter 29 (4) (2024)
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Yong Xie, Xu Shu, Nong Hua Lu, Yin Zhu
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter 27 (5) (2022)
Cong He, Chao Peng, Xinbo Xu, Nianshuang Li, Yaobin Ouyang, Yin Zhu, Nong Hua Lu
Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota. Helicobacter 27 (4) (2022)
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Yong Xie, Xu Shu, Nong Hua Lu, Yin Zhu
Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study. Helicobacter 27 (4) (2022)
Nianshuang Li, Xinbo Xu, Hui Yang, Huan Wang, Yaobin Ouyang, Yanan Zhou, Chao Peng, Zhenxiang Yuan, Cong He, Chunyan Zeng, Jun-Bo Hong
Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial-mesenchymal transition via the MEK/ERK pathway. Helicobacter 26 (5) (2021)